Recruiting

Cerebrotendinous Xanthomatosis (CTX) Prevalence Study

Sponsor:

Travere Therapeutics, Inc.

Code:

NCT02638220

Conditions

Cerebrotendinous Xanthomatosis (CTX)

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information